Feb 20, 2026 06:22AM
Feb 19, 2026 04:05PM
Jan 30, 2026 04:53AM
Dec 18, 2025 07:00AM
Dec 18, 2025 07:00AM
Dec 9, 2025 07:00AM
Dec 9, 2025 07:00AM Pulse Biosciences, Inc. Announces Initiation of Research Collaboration for the Treatment of Benign and Malignant Thyroid Tumors with nPulse™ Technology
Nov 5, 2025 04:05PM
Oct 24, 2025 07:00AM
Oct 24, 2025 07:00AM
Oct 7, 2025 07:00AM
Sep 8, 2025 07:02AM
Sep 8, 2025 07:00AM
Aug 12, 2025 04:05PM Pulse Biosciences Reports Business Updates and Second Quarter 2025 Financial Results
May 8, 2025 04:05PM
Apr 23, 2025 07:00AM
Mar 27, 2025 04:05PM
Jan 30, 2025 08:00AM
Jan 10, 2025 08:04AM
Jan 10, 2025 08:00AM
Dec 17, 2024 08:00AM Pulse Biosciences Announces Publication in the Journal of Thoracic and Cardiovascular Surgery
Oct 31, 2024 02:25PM
Oct 31, 2024 02:25PM
Oct 30, 2024 04:05PM
Aug 12, 2024 04:05PM
Aug 8, 2024 08:00AM
Jul 8, 2024 08:09AM
Jul 8, 2024 08:00AM Pulse Biosciences, Inc. Announces Receipt of FDA Breakthrough Device Designation for CellFX® nsPFA Cardiac Surgery System for the Treatment of Atrial Fibrillation
May 14, 2024 04:05PM
May 9, 2024 08:00AM
May 7, 2024 04:05PM
Mar 28, 2024 04:12PM
Mar 8, 2024 01:17PM
Mar 8, 2024 01:17PM
Jan 2, 2024 08:00AM Pulse Biosciences, Inc. (PLSE) Files 510(k) Submission with U.S. FDA for its CellFX nsPFA™ Cardiac Clamp
Jan 2, 2024 08:00AM
Dec 20, 2023 08:05AM
Dec 20, 2023 08:00AM
Nov 21, 2023 08:01AM
Nov 21, 2023 08:00AM
Nov 13, 2023 08:00AM
Aug 24, 2023 04:05PM Pulse Biosciences Clarifies Details of Recent S-3 Filing
Aug 10, 2023 04:05PM
May 11, 2023 04:05PM
Mar 30, 2023 04:05PM
Oct 6, 2022 08:04AM
Oct 6, 2022 08:00AM
Sep 26, 2022 08:00AM
Sep 26, 2022 08:00AM Pulse Biosciences Announces FDA 510(k) Clearance for the Treatment of Sebaceous Hyperplasia
Aug 10, 2022 04:05PM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All